Doxycycline Monohydrate Capsule
NDC Package 62135-261-01
Package Information
Doxycycline Monohydrate capsules is to reduce the development of drug-resistant bacteria and maintain effectiveness of doxycycline capsules and other antibacterial drugs, doxycycline capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. This formulation utilizes a capsule delivery system. Marketed by Chartwell Rx, Llc., this product is identified by NDC 62135-261 and is authorized under FDA application NDA050641.
Identification & Billing
- RxCUI: 1649401 - doxycycline monohydrate 50 MG Oral Capsule
- RxCUI: 1649990 - doxycycline monohydrate 100 MG Oral Capsule
- RxCUI: 700408 - doxycycline monohydrate 75 MG Oral Capsule
- RxCUI: 728207 - doxycycline monohydrate 150 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 62135 - Chartwell Rx, Llc.
- 62135-261 - Doxycycline Monohydrate
- 62135-261-01 - 100 CAPSULE in 1 BOTTLE
- 62135-261 - Doxycycline Monohydrate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 62135-261-01 identifies a specific commercial package of 100 capsule in 1 bottle of Doxycycline Monohydrate, a human prescription drug labeled by Chartwell Rx, Llc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This capsule is formulated for oral use and contains doxycycline as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Chartwell Rx, Llc. on December 29, 1989. The current certification is valid through December 31, 2027.
How is this Chartwell Rx, Llc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 62135026101. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.